Emcure Pharmaceuticals (NSE:EMCURE) Tax Rate %: 25.67% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:EMCURE Emcure Pharmaceuticals Ltd NSE:EMCURE
42 GF Score
Price ₹1,862.30
! 5 Warning Signs
View Full Analysis

What is Emcure Pharmaceuticals Tax Rate %?

Emcure Pharmaceuticals NSE:EMCURE +0.83% 42 Tax Rate % is 25.67% as of Jun. 2026. GuruFocus rates NSE:EMCURE with a GF Score™ of 42/100. The stock has 5 warning signs investors should review.

Tax Rate % is calculated as Tax Expense divided by its Pre-Tax Income. Emcure Pharmaceuticals's Tax Expense for the three months ended in Jun. 2026 was ₹1,010 Mil. Emcure Pharmaceuticals's Pre-Tax Income for the three months ended in Jun. 2026 was ₹3,935 Mil. Therefore, Emcure Pharmaceuticals's Tax Rate % for the quarter that ended in Jun. 2026 was 25.67%.

Emcure Pharmaceuticals Tax Rate % Related Terms

Emcure Pharmaceuticals Tax Rate % Historical Data

* Premium members only.

The historical data trend for Emcure Pharmaceuticals's Tax Rate % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Emcure Pharmaceuticals Tax Rate % Chart

Emcure Pharmaceuticals Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Tax Rate %
Get a 7-Day Free Trial 27.76 24.81 27.45 27.17 26.87

Emcure Pharmaceuticals Quarterly Data
Mar21 Mar22 Mar23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Tax Rate % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 26.13 26.37 26.27 28.56 25.67
NSE:EMCURE
42GF Score
Emcure Pharmaceuticals Ltd NSE:EMCURE
Tax Rate % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Emcure Pharmaceuticals Tax Rate % Calculation

Tax Rate % is the ratio of tax expense divided by pretax income, usually presented in percent.

Emcure Pharmaceuticals's Tax Rate % for the fiscal year that ended in Mar. 2026 is calculated as

Tax Rate %=Tax Expense (A: Mar. 2026 )/Pre-Tax Income (A: Mar. 2026 )
=3458.74/12871.43
=26.87 %

Emcure Pharmaceuticals's Tax Rate % for the quarter that ended in Jun. 2026 is calculated as

Tax Rate %=Tax Expense (Q: Jun. 2026 )/Pre-Tax Income (Q: Jun. 2026 )
=1010.33/3935.26
=25.67 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Tax Rate % →
What does a Tax Rate % of 25.67% mean?
Emcure Pharmaceuticals (NSE:EMCURE) has a Tax Rate % of 25.67% as of Jun. 2026.
Is Emcure Pharmaceuticals' Tax Rate % too high?
Emcure Pharmaceuticals' current Tax Rate % is 25.67%. Overall, Emcure Pharmaceuticals has a GF Score™ of 42/100, reflecting its overall financial health beyond just this single metric.
How does Emcure Pharmaceuticals' Tax Rate % compare to ZTS?
Emcure Pharmaceuticals' Tax Rate % of 25.67% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tax Rate % for a Drug Manufacturers company?
A good Tax Rate % depends on the Drug Manufacturers industry context. However, Tax Rate % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tax Rate % mean?
A high Tax Rate % can signal that a stock is expensive relative to its fundamentals. Emcure Pharmaceuticals's current Tax Rate % is 25.67%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Emcure Pharmaceuticals stock overvalued right now?
Emcure Pharmaceuticals (NSE:EMCURE) has a current Tax Rate % of 25.67%. The current Tax Rate % is 25.67%. Emcure Pharmaceuticals' overall GF Score™ is 42/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tax Rate % calculated?
Tax Rate % is calculated from a company's financial statements. For Emcure Pharmaceuticals (NSE:EMCURE), the current Tax Rate % is 25.67% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Emcure Pharmaceuticals Business Description

Other Exchanges 544210:India
Address Plot No. P-1 and P-2, IT-BT Park, Phase II, M.I.D.C., Hinjawadi, Pune, MH, IND, 411 057
Emcure Pharmaceuticals Ltd an Indian pharmaceutical company engaged in developing, manufacturing and globally marketing a range of pharmaceutical products across several therapeutic areas. Its portfolio includes orals including solids, liquid orals and dry syrup/suspensions., injectables such as vials and pre-filled syringes, and forms such as lyophilized & liquid and biotherapeutics. The company operates in Derma, Women's Health, Cardiovascular, Neurology, Oncology, Vaccines, and Anti-infectives. Geographically, it operates in India, Europe, Canada, Vietnam, Dubai, and Other Countries.
42GF Score

Get the complete analysis for NSE:EMCURE

Tax Rate % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,862.30
Price